Cancer BiologybioRxivPreprint
ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer
R. Garnham, D. Geh, R. Nelson…·E. Scott
This study shows ST3Gal1 promotes immune evasion in prostate cancer by synthesizing Siglec ligands, and its activity can be modulated by enzalutamide.
DOI 10.1101/2023.04.03.535346